These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 271848)

  • 1. Intensified adverse drug reaction reporting scheme.
    N Z Med J; 1977 Jun; 85(589):477. PubMed ID: 271848
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adverse effects registration in Denmark. Comments on a new reporting scheme].
    Ugeskr Laeger; 1972 May; 134(21):1114-5. PubMed ID: 5045779
    [No Abstract]   [Full Text] [Related]  

  • 3. New Zealand Committee on Adverse Drug Reactions. 6th annual report.
    N Z Dent J; 1971 Oct; 67(310):253-62. PubMed ID: 5291449
    [No Abstract]   [Full Text] [Related]  

  • 4. New Zealand Committee on Adverse Drug Reactions: Twelfth Annual Report 1977.
    McQueen EG
    N Z Med J; 1977 Sep; 86(595):248-50. PubMed ID: 272526
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacist and adverse drug reaction reporting.
    Pearson K
    Hosp Pharm; 1982 Aug; 17(8):421-2, 427-30. PubMed ID: 10256700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.
    Moore N; Thiessard F; Begaud B
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):285-6. PubMed ID: 15782397
    [No Abstract]   [Full Text] [Related]  

  • 7. [New rules in reporting adverse effects of drugs].
    Böttiger LE
    Lakartidningen; 1974 Dec; 71(51):5288-90. PubMed ID: 4449293
    [No Abstract]   [Full Text] [Related]  

  • 8. The need for pharmacists' cooperation in national adverse drug reaction reporting.
    Lee B; Groth PE
    Hosp Formul; 1978 Nov; 13(11):888-91, 895. PubMed ID: 10239344
    [No Abstract]   [Full Text] [Related]  

  • 9. Food and Drug Administration's adverse drug reaction monitoring program.
    Lee B; Turner WM
    Am J Hosp Pharm; 1978 Aug; 35(8):929-32. PubMed ID: 677138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving how we evaluate the toxicity of approved drugs.
    Reidenberg MM
    Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311
    [No Abstract]   [Full Text] [Related]  

  • 11. Unreported adverse drug reactions determined by screening physician orders for diphenhydramine.
    Fraterrigo CC; Estep JM; Palmer MA
    Hosp Pharm; 1981 Aug; 16(8):421-3, 426. PubMed ID: 10252375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of reporting systems of adverse reactions to drugs and care.
    Jorup-Rönström C; Britton S
    Scand J Soc Med; 1983; 11(3):87-9. PubMed ID: 6669976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The national registry of drug-induced ocular side effects.
    Fraunfelder FT; Meyer SM
    Aust J Ophthalmol; 1984 May; 12(2):129-31. PubMed ID: 6487182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How pharmacists can speed new drug approval through ADR reporting.
    Kennedy D
    Pharm Times; 1978 Mar; 44(3):44-8. PubMed ID: 10307082
    [No Abstract]   [Full Text] [Related]  

  • 15. New Zealand Committee on Adverse Drug Reactions: fourteenth annual report 1979.
    McQueen EG
    N Z Dent J; 1980 Apr; 76(344):65-9. PubMed ID: 6929959
    [No Abstract]   [Full Text] [Related]  

  • 16. New Zealand Committee on Adverse Drug Reactions: three-year survey of reactions, 1969-1971.
    N Z Med J; 1972 Feb; 75(477):100-4. PubMed ID: 4502692
    [No Abstract]   [Full Text] [Related]  

  • 17. New Zealand Committee on Adverse Drug Reactions: reactions reported 1965-1968.
    N Z Med J; 1969 Feb; 69(441):96-9. PubMed ID: 5252211
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reporting on side effects-complications with drug therapy].
    Skobba J
    Nor Tannlaegeforen Tid; 1972 Mar; 82(3):131-7. PubMed ID: 4502689
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug associated hepatic reactions in New Zealand: 21 years experience.
    Pillans PI
    N Z Med J; 1996 Aug; 109(1028):315-9. PubMed ID: 8816722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Zealand Committee on Adverse Drug Reactions. Ninth annual report.
    N Z Dent J; 1975 Jan; 71(323):28-32. PubMed ID: 1059029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.